The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy of systemic sequential regorafenib after TACE combined with first-line targeted drugs (donafenib, sorafenib, or lenvatinib) after treatment failure for advanced hepatocellular carcinoma: A retrospective, single-center, real-world study.
 
Ning Wei
No Relationships to Disclose
 
Dong Lu
No Relationships to Disclose
 
Chunze Zhou
No Relationships to Disclose
 
Delei Cheng
No Relationships to Disclose
 
Zhengfeng Zhang
No Relationships to Disclose
 
Xingming Zhang
No Relationships to Disclose
 
Jingkun Xiao
No Relationships to Disclose
 
Weifu Lv
No Relationships to Disclose